Advanced search
Publication Cover
Acta Oncologica Volume 27, 1988 - Issue 1
Journal homepage
316
Views
18
CrossRef citations to date
0
Altmetric
Miscellaneous Article

Renal Insufficiency in Patients Treated with High Dose Methotrexate

A. G. Maiche Department of Radiotherapy, Oncology Helsinki University Central Hospital, SF-00290, Helsinki 29, Finland
,
K. Lappalainen Department of Radiotherapy, Oncology Helsinki University Central Hospital, SF-00290, Helsinki 29, Finland
&
L. Teerenhovi Department of Radiotherapy, Oncology Helsinki University Central Hospital, SF-00290, Helsinki 29, Finland
Pages 73-74 | Accepted 01 May 1987, Published online: 08 Jul 2009

References

  • Adams D. H., Michael J., Bacon P. A. Non-steroidal anti-inflammatory drugs and renal failure. Lancet 1986; 57
  • Djerassi I. High-dose methotrexate (NSC-740) and citrovorum factor (NSC-3590) rescue. Background and rationale. Cancer Chemother. Rep. 1975; 6: 3
  • Gaffen J. D., Bennett A., Barer M. R. A new method for studying cell growth in suspension and its use to show that indomethacin enhances cell killing by methotrexate. J. Pharm. Pharmacol. 1985; 37: 261
  • Jaffe N., Frej I E., II, Traggis D., Cassady J. R., Watts H., Filler R. M. High-dose methotrexate with citrovorum factor in osteogenic sarcoma-Progress report II. Cancer Treat. Rep. 1977; 61: 675
  • Maiche A. G. Acute renal failure due to concomitant action of methotrexate and indomethacin. Lancet 1986; 1390
  • Markman M., Newman D. R., Hawkins R. S. Acute renal failure and death following sequential intermediate-dose methotrexate and 5-FU. A possible adverse effect due to concomitant indomethacin administration. Cancer Treat. Rep. 1985; 69: 342
  • Nirenberg A., Mosende C, Mehta B. M., Gisolfi A. L., Rosen G. High-dose methotrexate with citrovorum factor rescue. Predictive value of serum methotrexate concentrations and correlative measures to avert toxicity. Cancer Treat. Rep. 1977; 61: 779
  • Pitman S. W., Parker L. M., Tattersall M. H. N., Jaffe N., Frei I E, II. Clinical trial of high-dose methotrexate (NSC-740) with citrovorum factor (NSC-3590)—Toxicologic and therapeutic observations. Cancer Chemother. Rep. 1975; 6: 43
  • Pratt C. B., Roberts D., Shanks E., Warmath E. L. Response, toxicity and pharmacokinetics of high-dose methotrexate (NSC-740) with citrovorum factor (NSC-3590) rescue for children with osteosarcoma and other malignant tumors. Cancer Chemother. Rep. 1975; 6: 13
  • Singh R. R., Malaviya A. N., Pandey J. N., Guleria J. S. Fatal interaction between methotrexate and naproxen. Lancet 1986; 1390
  • Thyss A., Kubar J., Milano G. Clinical and pharmacokinetic evidence of a life-threatening intercation between methotrexate and ketoprofen. Lancet 1986; 256

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.